Consultation Successes

Health economic evaluation findings assist stakeholders in improving the quality, availability, scalability, and sustainability of evidence-based services, and in maximizing the efficiency of service delivery. We designed a free consultation service to provide health-economic methodological guidance among substance use, HCV, and HIV researchers. The service includes up to six hours of consulting time. After prospective consultees submit their request online, they receive a screening call from the consultation service director, who connects them with a consultant with relevant expertise. Consultees and consultants complete web-based evaluations following the consultation; consultees also complete a six-month follow-up. We have conducted over 90 consultations since 2015, and have helped investigators improve economic evaluation, and incorporate economic methods in substance use research. Below we describe several consultation success stories that have resulted in grant funding or publication.



Approximately 1.6 million US adults used methamphetamine each year from 2015 to 2018, many of whom had co-occurring substance use or mental illness. Higher rates of methamphetamine use were concentrated in non-urban areas, which raises concerns due to limited substance use treatment availability in outside of urban areas. Stimulant use is associated with increased risk […]

Read the blog post

The incidence of neonatal abstinence syndrome (NAS), also known as neonatal withdrawal syndrome, increased nationally from 3.4 per 1000 hospital births in 2009 to 5.8 in 2012. Recent estimates of NAS cost $1.5 billion dollars with the majority of the financial burden falling to state Medicaid programs. However, pregnancy offers a unique opportunity for women […]

Read the blog post

Hospital-based consultation services that link inpatients with opioid use disorders to treatment offer a unique opportunity to narrow the treatment gap that results in only a minority of individuals with opioid use disorders receiving evidence-based treatment.  Dr. Jennifer McNeely recently received R01 funding from the National Institute on Drug Abuse (NIDA) to study the Consult […]

Read the blog post

Between 1999 and 2015, the annual sales of opioid analgesics in the US quadrupled to about $8 billion dollars. In an effort to address over-prescribing of opioid analgesics, Dr. Marcus Bachhuber recently received a career development award (K-award) from the National Institute on Drug Abuse (NIDA) to implement a default opioid prescribing system in the […]

Read the blog post

Dr. Bulat Idrisov is a National Institute on Drug Abuse (NIDA) International Program INVEST Drug Abuse Research Fellow under the mentorship of Dr. Jeffrey Samet, CHERISH HCV/HIV co-director. Dr. Idrisov completed his medical training in pediatrics and internal medicine in Russia and received a Fulbright Scholarship to complete his Master of Science in Global Health […]

Read the blog post

Dr. Alysse Wurcel is an infectious disease specialist and faculty member at Tufts University School of Medicine with a focus in HIV and hepatitis C (HCV) infection whose research interests closely align with her clinical work. Dr. Wurcel’s research is focused on the treatment of HCV in people who inject drugs (PWID), people in the criminal […]

Read the blog post